Download Brochure

Please complete the information below to complete your download.

Please note: That all fields marked with an asterisk (*) are required.

First Name *
Last Name *
Job Title *
Company Name *
Email Address *
Telephone *
Country *
Where did you hear about us? *

I would like to receive information about sponsorship and exhibition opportunities

Yes, sign me up for the FREE Pharma IQ e-newsletter, including information on FREE Podcasts, Webinars, event discounts and online learning opportunities.



Current Challenges and Future Developments for Drug Safety in Emerging Markets

Posted: 10/14/2010


To View Full Video Content, Please Join Now:
To continue viewing this content please fill out the form below and become an IQ member.
Or if you're already a Pharma IQ member, sign in to download.

First Name*
Last Name*
Job Title*
Company*
Country
State
E-mail*
Username*
Password*
Confirm Password*

By clicking Submit, you accept our User Agreement, Privacy Policy, and Cookie Policy.

Tags:  Monica Rusu | pharmacoviligance | drug safety | emerging markets | risk management | global PV systems | risk management plans | pharmacovigilance strategies | patient safety | risk management strategies | Abbott

Drug safety has never been more important. Patient's attitudes to risk have changed significantly and negative perceptions of a product can have devastating effects on the reputation of the developer.

Regulatory
hurdles and rule changes on risk management have also increased the pressures on drug developers to ensure sound pharmacovigilance processes are in place.

Presented by Dr. Monica Rusu Director, Pharmacovigilance EELA, Abbott Products GmbH, at IQPC's Pharmacovigilance and Risk Management Strategies in June 2010.

Rusu discusses:

  • The local regulatory environment and expectations of competent authorities
  • Developing risk management plans to conform to differen regulatory standards
  • Challenges for the global PV systems
  • Identifying commonalities across the emerging markets for a more standardised approach to risk management

  Have Your Say
Rate this feature and give us your feedback in the comments section below


comments powered by Disqus


Advertise With Us

Join the Pharmas IQ Community